secwatch / observer
8-K filed May 30, 2025, 7:59 PM ET ticker MCK CIK 0000927653
M&A confidence high sentiment positive materiality 0.75

MCKESSON CORP (MCK): debt financing — McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization

MCKESSON CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

MCKESSON CORP incurred senior notes of $650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030 at 4.650% maturing 2030.

Instrument
senior notes
Principal
$650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030
Rate
4.650%
Maturity
2030
Event
incurrence
Exact text from the filing
$650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030 (the "2030 Notes"), $650,000,000 in aggregate principal amount of the Company's 4.950% Notes due 2032 (the "2032 Notes") and $700,000,000 in aggregate principal amount of the Company's 5.250% Notes due 2035 (the "2035 Notes" and, together with the 2030 Notes and 2032 Notes, the "Notes")
View on SEC.gov

Browse all debt financings →

MCKESSON CORP filing history →

Source: SEC EDGAR
accession 0001628280-25-028495
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.